SCHEDULE 13G/A: Pacer Funds and Affiliates Disclose Passive Stake in Pacira BioSciences

Sentiment:

Beneficial Ownership Report


Pacer US Small Cap Cash Cows ETF, Pacer US Small Cap Cash Cows Growth Leaders ETF, Pacer Advisors, Inc., and Joe M. Thomson have jointly filed an amended Schedule 13G, disclosing a combined passive beneficial ownership of 1.28% in Pacira BioSciences, Inc.

Summary

  • Pacer US Small Cap Cash Cows ETF, Pacer US Small Cap Cash Cows Growth Leaders ETF, Pacer Advisors, Inc., and Joe M. Thomson (collectively, the "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership of common stock in Pacira BioSciences, Inc.
  • The filing indicates that the Reporting Persons collectively beneficially own 601,668 shares of Pacira BioSciences, Inc. common stock.
  • This aggregate amount represents 1.28% of the issuer's common stock outstanding, based on 47,077,844 shares issued and outstanding as of December 31, 2024.
  • The shares are held with shared voting power and shared dispositive power among the Reporting Persons.
  • The acquisition of these securities was made in the ordinary course of business and not for the purpose of changing or influencing the control of Pacira BioSciences, Inc.

Sentiment

Score: 5

Explanation: The document is a routine Schedule 13G filing disclosing passive beneficial ownership, which is neutral in sentiment. It does not contain information that would typically indicate positive or negative developments for the issuer or the reporting persons beyond the ownership disclosure itself.

Future Outlook

NA

Management Comments

  • "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ยงยง 240.14a-11."

Industry Context

This filing is a routine disclosure of passive beneficial ownership by investment funds and their adviser, common in the financial industry for transparency regarding significant, non-controlling stakes in publicly traded companies. It reflects standard portfolio management activities rather than a strategic industry move.

Stakeholder Impact

  • Shareholders: Provides transparency regarding a passive institutional ownership stake, confirming that a significant portion of shares is held by investment funds for ordinary business purposes.
  • Company Management: Confirms that the reported stake is not intended to influence or change control of the company, allowing management to continue current strategic initiatives without immediate pressure from this specific shareholder group.

Key Dates

DateDescription
2024-12-31Date as of which the number of Pacira BioSciences, Inc. common shares outstanding (47,077,844) was reported by the Issuer.
2025-03-31Date of event which requires the filing of this statement.
2025-05-02Date of filing of this Schedule 13G Amendment.

Keywords

SEC filing, Schedule 13G, beneficial ownership, Pacira BioSciences, Pacer US Small Cap Cash Cows ETF, Pacer US Small Cap Cash Cows Growth Leaders ETF, Pacer Advisors Inc., Joe M. Thomson, common stock, investment adviser, passive investment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.